The STAMPEDE cancer trial has been responsible for improving the lives of hundreds of prostate cancer patients in Wales. Yesterday we marked the recruitment of the trial’s 10,000th patient at a celebratory event at the Welsh Assembly in Cardiff Bay.
STAMPEDE is now one of the world’s biggest cancer trials. This is an incredible achievement for prostate cancer research as a whole, especially here in Wales. In 2005, the very first patient was recruited to the study at Velindre Cancer Centre in Cardiff. Today, STAMPEDE is the largest ever prostate cancer treatment trial, and Velindre remains the largest recruiting centre. Many patients have also been treated on the trial in Singleton, Glangwili General and Bronglais General Hospitals.
The evening featured talks from Prof John Staffurth, Prof John Wagstaff, Dr Jason Lester and patient Tim Driscoll. The event was sponsored by Dawn Bowden AM, who is committed to improving access to clinical trials for patients in Wales.
A group of over 25 researchers, patients and third sector representatives gathered to celebrate the success to date and learn more about where the trial is going in the future.